Paclitaxel eluting balloon and sirolimus eluting balloon, many weapons against a common enemy: The in-stent restenosis

Affiliations

Comment

Davide Piraino. Int J Cardiol. 2017.

. 2017 Sep 1:242:4.

doi: 10.1016/j.ijcard.2017.03.035.

¹ Interventional Cardiology, "P.Giaccone" Universitary Hospital of Palermo, Italy. Electronic address: pirainod@libero.it.

No abstract available

Comment on

Treatment for in-stent restenosis using drug-eluting balloon: Importance of procedural optimization rather than device itself.
Lee JM, Rhee TM, Park J, Kim HS. Lee JM, et al. Int J Cardiol. 2017 Sep 1;242:5. doi: 10.1016/j.ijcard.2017.02.110. Int J Cardiol. 2017. PMID: 28619351 No abstract available.
Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus first generation drug-eluting balloon. A balanced comparison?
Piraino D. Piraino D. Int J Cardiol. 2017 Sep 1;242:6. doi: 10.1016/j.ijcard.2017.01.100. Int J Cardiol. 2017. PMID: 28619352 No abstract available.